Credit: Pixabay.com A study by University of Tartu researchers indicates that the sensitivity of tests used to detect viral antibodies in a blood sample may differ...
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just...
Bioprocessors have had a good handle on viral safety, but they need to keep their grip as they shift toward continuous processing and boost production of...
Innovative genomic methods are looking beyond raw DNA sequences and surveying areas such as haplotype phasing, epigenetics, and structural variants. The post Genomics Analysis Moves to...
"This Gives Some Hope" - Japanese Study Finds 98% Of COVID Patients Still Have Antibodies 6 Months Later Tyler Durden Wed, 12/02/2020 - 21:40 In another...
AI Just Solved A 50-Year-Old Mystery That Could "Dramatically" Change How We Fight Cancer Tyler Durden Wed, 12/02/2020 - 18:40 On the day our technological AI...
Switzerland’s Roche Holding AG announced on Wednesday that its Elecsys test, which seeks to detect antibodies against the SARS-CoV-2 spike protein, has been granted emergency use...
The answer could be found in death rates among the elderly.
On Nov. 9, Novavax R&D chief Gregory Glenn was awakened on his family farm to a news alert: Pfizer and BioNTech’s vaccine was more than 90%...
For use as an at-home IoT biosensor Credit: COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RESERVED. Overview: Associate Professor Kazuhiro Takahashi and Assistant Professor Yong-Joon...
Credit: Layla Aerts for KU Leuven Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate against Covid-19 based on the yellow...
Moderna and Pfizer-BioNTech are in a tight race to launch their Covid-19 vaccines in Europe after the companies applied for emergency EU approval on Dec. 1,...
Europe’s health regulator started a real-time review of Johnson & Johnson’s Covid-19 vaccine candidate after preliminary results showed that the shot triggered the production of antibodies...
The low-cost electrochemical technology for multiplexed biomarker detection could facilitate global serological testing for SARS-CoV-2 infections, and help trace immunity in individuals over time Credit: Credit:...
Credit: Douglas Levere/ University at Buffalo BUFFALO, N.Y. — Anyone who has undergone a nasal swab or saliva test for COVID-19 knows that the virus is...
COVID Antibody Drugs From Regeneron, Eli Lilly Raise Concerns About Supply Shortages Tyler Durden Sat, 11/28/2020 - 17:30 Powerful drugs recently authorized by the FDA are...
Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be The post Cheap gout drug colchicine added to...
Connor's work has covered important material in prescient ways, and done so with clarity and informative eloquence.
Plasma from recovered patients shows little benefit in those hospitalized with COVID-19: study (Reuters) – Using blood plasma from COVID-19 survivors to treat patients with severe...
Maryland-based Altimmune Inc. has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to commence a Phase 1 clinical study of its...
Credit: Tohoku University The future could hold portable and wearable sensors for detecting viruses and bacteria in the surrounding environment. But we’re not there yet. Scientists...
Generally, companies in the healthcare sector show resilience amid challenging macro conditions. However, certain healthcare stocks have been under pressure during the pandemic due to supply...
The U.S. government will start distributing Regeneron Pharmaceuticals Inc.’s newly authorized Covid-19 antibody combination on Nov. 24, beginning with more than 30,000 treatment courses, a health...
CNBC Transcript: Regeneron Chairman and CEO Dr. Leonard Schleifer speaks With CNBC’s Meg Tirrell on “Squawk Box” today on the distribution of Covid-19 antibody cocktail. Q3...
First on CNBC: CNBC Transcript: Dr. Ruud Dobber, President of AstraZeneca US and EVP of BioPharmaceuticals, speaks with CNBC’s “Squawk Box” today explaining their positive Covid...
AstraZeneca is preparing to file its COVID-19 vaccine with regulators after phase 3 trial results showed it is The post AZ preps filings for COVID-19 jab,...
UK Government Proposes "Freedom Passes" To Get 'Safe' People Back To Work Tyler Durden Mon, 11/23/2020 - 04:15 The rollout of COVID-19 immunity certificates across the...
The U.S. Food and Drug Administration issued emergency use authorization for Regeneron Pharmaceuticals Inc.’s Covid-19 antibody therapy, an experimental treatment given to U.S. President Donald Trump...
Regeneron announced that its REGN-COV2 investigational antibody cocktail therapy for the treatment of COVID-19, has been granted Emergency Use Authorization (EUA) by the US Food and...
In the disturbing scenario of human-to-mink-to-human COVID-19 transmission, the virus may mutate in mink prior to re-infecting people. That possibility makes vaccine design even more crucial.